AMGN
Amgen

Conference date: April 22, 2014 @ 2:15 PM Pacific Time

Amgen initial purchase March 24, 2014
Amgen with Onyx Pharmaceuticals: Long Term Analysis September 4, 2013

Analyst Conference Summaries and reports available:

2014
Amgen
Analyst Call
Q1 2014
4/22/2014
2013
Not available
Amgen
Analyst Call
Q2 2013
 
Amgen
Analyst Call
Q3 2013
Amgen
Analyst Call
Q4 2013
 
 07/30/2013
10/22/2013
01/28/2014

 

 

 

 

 

 

Amgen Valuation [blog 12/3/2007]

I did not follow Amgen closely between the end of 2008 and mid-2013.

2008
Amgen analyst conference summary Q3 2008
Amgen analyst conference summary Q2 2008
Amgen Q1 2008 analyst conference summary
Amgen analyst conference summary Q4 2007
Q3 2008
Q2 2008
Q1 2008
Q4 2007
10/22/2008
07/28/2008
04/24/2008
1/24/2008
2007
Amgen Q3 analyst conference summary
amgn Q2 2007
amgen summary
10/24/2007
07/26/2007
4/23/2007

 01/25/2007
Q3 2007
Q2 2007
Q1 2007

 Q4 2006

Amgen is a biotechnology therapeutics company selling a variety of drugs, notably Arenesp, Epogen and Enbrel.

I own Amgen

Amgen Web site:

Amgen home page
investor page

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but its possible. Before making or terminating an investment you should always verify any factual basis of your decision.